Table 1.
Baseline characteristics of the study population.
| Low recurrence rate | High recurrence rate | p-value (P3 vs. P2) | |
|---|---|---|---|
| N | 49 | 10 | |
| Faecal sample | 46 | 10 | |
| Female, n (%) | 93.9% | 100% | |
| Age, years | 43.0 | 47.5 | 0.568 |
| BMI, kg/m2 | 22.3 | 23.9 | 0.202 |
| Work (2), n (%) | 33 (84.6%) | 8 (80.0%) | 0.659 |
| High-oil diet, n (%) | 5 (12.8%) | 1 (10.0%) | 0.781 |
| High-salt diet, n (%) | 11 (38.3%) | 2 (20.0%) | 0.315 |
| Smoker, n (%) | 2 (5.13%) | 0 (0.0%) | 1 |
| Drink alcohol, n (%) | 2 (5.13%) | 1 (5.3%) | 1 |
| Sports frequency (1, 2) (%) | 26 (66.7%) | 4 (40.0%) | 0.384 |
| Sports strength (1, 2) (%) | 7 (17.9%) | 0 (0.0%) | 0.412 |
| AQP4-IgG, n (%) | 49 (100%) | 10 (100%) | – |
| ARR, mean | 0.4 | 1.0 | ≤0.001 |
| Course of disease, years | 6 | 1.5 | 0.023 |
| EDSS, mean | 3.0 | 2.75 | 0.955 |
| mRS, n (%) | 0.907 | ||
| 0 | 2 (5.13%) | 1 (10.0%) | |
| 1 | 26 (66.7%) | 7 (70.0%) | |
| 2 | 9 (23.1%) | 2 (20.0%) | |
| 3 | 2 (5.13%) | 0 (0.00%) | |
| Immunosuppressant | 0.419 | ||
| Azathioprine | 11 (22.4%) | 2 (20.0%) | |
| Mycophenolate mofetil | 23 (46.9%) | 7 (70.0%) |
ARR, annual recurrence rate; EDSS, Expanded Disability Status Scale; mRS, modified Rankin Scale.